Prevalence, awareness, treatment, and control of hypertension in older people: results from the population-based KORA-age 1 study.
Aged
Aged, 80 and over
Antihypertensive Agents
/ therapeutic use
Awareness
Blood Pressure
Blood Pressure Determination
/ statistics & numerical data
Cross-Sectional Studies
Diabetes Mellitus
/ epidemiology
Female
Germany
Humans
Hypertension
/ epidemiology
Logistic Models
Male
Mass Screening
Middle Aged
Obesity
/ epidemiology
Odds Ratio
Prevalence
Risk Factors
Awareness
Control
Hypertension
Older adults
Prevalence
Treatment
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
02 Jul 2020
02 Jul 2020
Historique:
received:
04
02
2020
accepted:
24
06
2020
entrez:
4
7
2020
pubmed:
4
7
2020
medline:
29
10
2020
Statut:
epublish
Résumé
Hypertension remains a significant modifiable risk factor for cardiovascular diseases and a major determinant of morbidity and mortality. We aimed to describe sex-stratified age-standardized estimates of prevalence, awareness, treatment and control of hypertension, and their associated factors in older adults. The KORA-Age1 is a population-based cross-sectional survey carried out in 2008/2009 on individuals aged 65-94 years in Augsburg region, Germany. Blood pressure measurements were available for 1052 out of 1079 persons who participated in the physical examination. Factors associated with prevalence, awareness and control of hypertension were investigated by multivariable logistic regression. The overall prevalence of hypertension (≥140/90 mmHg) was 73.8% [95% confidence interval (CI), 69.3-77.9], representing 74.8% (95% CI, 68.4-80.2) in men and 73.5% (95% CI, 66.8-79.3) in women. Among those with hypertension, 80.2% (95% CI, 75.3-84.4) were aware of their hypertensive condition and 74.4% (95% CI, 69.2-79.1) were on treatment for hypertension. Among those aware of their hypertension status, 92.8% (95% CI, 88.8-95.6) were on treatment and 53.7% (95% CI, 47.0-60.1) had their blood pressure controlled. Hypertension was more frequent in individuals who were older, obese, or had diabetes. Higher education attainment or presence of comorbidities was associated with higher level of hypertension awareness. Individuals taking three antihypertensive drug classes were more likely to have controlled hypertension compared with those taking one antihypertensive drug class, odds ratio (OR), 1.85 (95% CI, 1.14-2.99). Our findings identified high prevalence of hypertension and relevant health gaps on awareness, treatment and suboptimal control of hypertension in older adults in Germany. Screening for hypertension should especially target older adults with low educational attainment and 'healthy' elderly with less contact to physicians.
Sections du résumé
BACKGROUND
BACKGROUND
Hypertension remains a significant modifiable risk factor for cardiovascular diseases and a major determinant of morbidity and mortality. We aimed to describe sex-stratified age-standardized estimates of prevalence, awareness, treatment and control of hypertension, and their associated factors in older adults.
METHODS
METHODS
The KORA-Age1 is a population-based cross-sectional survey carried out in 2008/2009 on individuals aged 65-94 years in Augsburg region, Germany. Blood pressure measurements were available for 1052 out of 1079 persons who participated in the physical examination. Factors associated with prevalence, awareness and control of hypertension were investigated by multivariable logistic regression.
RESULTS
RESULTS
The overall prevalence of hypertension (≥140/90 mmHg) was 73.8% [95% confidence interval (CI), 69.3-77.9], representing 74.8% (95% CI, 68.4-80.2) in men and 73.5% (95% CI, 66.8-79.3) in women. Among those with hypertension, 80.2% (95% CI, 75.3-84.4) were aware of their hypertensive condition and 74.4% (95% CI, 69.2-79.1) were on treatment for hypertension. Among those aware of their hypertension status, 92.8% (95% CI, 88.8-95.6) were on treatment and 53.7% (95% CI, 47.0-60.1) had their blood pressure controlled. Hypertension was more frequent in individuals who were older, obese, or had diabetes. Higher education attainment or presence of comorbidities was associated with higher level of hypertension awareness. Individuals taking three antihypertensive drug classes were more likely to have controlled hypertension compared with those taking one antihypertensive drug class, odds ratio (OR), 1.85 (95% CI, 1.14-2.99).
CONCLUSION
CONCLUSIONS
Our findings identified high prevalence of hypertension and relevant health gaps on awareness, treatment and suboptimal control of hypertension in older adults in Germany. Screening for hypertension should especially target older adults with low educational attainment and 'healthy' elderly with less contact to physicians.
Identifiants
pubmed: 32616004
doi: 10.1186/s12889-020-09165-8
pii: 10.1186/s12889-020-09165-8
pmc: PMC7331188
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1049Références
Curr Rheumatol Rep. 2007 Apr;9(1):36-43
pubmed: 17437665
Drugs Aging. 2014 Dec;31(12):897-910
pubmed: 25323058
Z Gerontol Geriatr. 2011 Dec;44 Suppl 2:41-54
pubmed: 22270973
Hypertens Res. 2010 Dec;33(12):1223-31
pubmed: 20882026
Dtsch Arztebl Int. 2016 Dec 2;113(48):809-815
pubmed: 28073425
J Public Health (Oxf). 2016 Sep;38(3):450-458
pubmed: 25922371
J Cardiometab Syndr. 2007 Spring;2(2):114-8
pubmed: 17684464
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
J Am Heart Assoc. 2017 Nov 18;6(11):
pubmed: 29151036
PLoS One. 2013 Dec 09;8(12):e82566
pubmed: 24349311
BMJ. 2018 Jul 6;362:k2912
pubmed: 29980562
PLoS One. 2012;7(1):e30556
pubmed: 22291986
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
Ageing Res Rev. 2016 Mar;26:96-111
pubmed: 26835847
J Hypertens. 2017 Feb;35(2):250-258
pubmed: 27846042
Eur Heart J. 2014 Jul;35(26):1712-8
pubmed: 24302270
J Hypertens. 2006 Jan;24(1):51-8
pubmed: 16331101
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
J Hypertens. 2016 Mar;34(3):532-8; discussion 538
pubmed: 26771343
J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):256-63
pubmed: 19181717
J Hypertens. 2010 Oct;28(10):2127-33
pubmed: 20634719
Postgrad Med J. 2007 Feb;83(976):109-14
pubmed: 17308214
Circ Res. 2019 Mar 29;124(7):1045-1060
pubmed: 30920928
JAMA. 2010 May 26;303(20):2043-50
pubmed: 20501926
J Clin Hypertens (Greenwich). 2016 Jan;18(1):10-8
pubmed: 26215211
Stat Med. 2016 Dec 30;35(30):5730-5735
pubmed: 27460748
BMC Proc. 2013 Aug 23;7(Suppl 4 European Workshop on Health and Disability Surveilla):S10
pubmed: 24899920
J Am Geriatr Soc. 2007 Jul;55(7):1056-65
pubmed: 17608879
Medicine (Baltimore). 2015 Jun;94(22):e952
pubmed: 26039136
Drug Saf. 1997 Nov;17(5):277-89
pubmed: 9391772
Card Fail Rev. 2017 Nov;3(2):102-107
pubmed: 29387461
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
BMC Public Health. 2018 Feb 23;18(1):278
pubmed: 29471834